Literature DB >> 29224575

A systematic review of patient-reported outcome measures in paediatric otolaryngology.

J Powell1, S Powell1, A Robson2.   

Abstract

BACKGROUND: Recently, there has been increased emphasis on the development and application of patient-reported outcome measures. This drive to assess the impact of illness or interventions, from the patient's perspective, has resulted in a greater number of available questionnaires. The importance of selecting an appropriate patient-reported outcome measure is specifically emphasised in the paediatric population. The literature on patient-reported outcome measures used in paediatric otolaryngology was reviewed.
METHODS: A comprehensive literature search was conducted using the databases Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, and PsycInfo, using the terms: 'health assessment questionnaire', 'structured questionnaire', 'questionnaire', 'patient reported outcome measures', 'PROM', 'quality of life' or 'survey', and 'children' or 'otolaryngology'. The search was limited to English-language articles published between 1996 and 2016.
RESULTS: The search yielded 656 articles, of which 63 were considered relevant. This included general paediatric patient-reported outcome measures applied to otolaryngology, and paediatric otolaryngology disease-specific patient-reported outcome measures.
CONCLUSION: A large collection of patient-reported outcome measures are described in the paediatric otolaryngology literature. Greater standardisation of the patient-reported outcome measures used in paediatric otolaryngology would assist in pooling of data and increase the validation of tools used.

Entities:  

Keywords:  Children; Health Impact Assessment; Outcome Assessment (Health Care); Patient Reported Outcome Measures; Quality Of Life; Surveys And Questionnaires

Mesh:

Year:  2017        PMID: 29224575     DOI: 10.1017/S0022215117002420

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.

Authors:  Victoria Huang; Amanda L Bergner; Chris Halpin; Vanessa L Merker; Monica R Sheridan; Brigitte C Widemann; Jaishri O Blakeley; Scott R Plotkin
Journal:  Otol Neurotol       Date:  2018-06       Impact factor: 2.311

2.  A visual analog scale for patient-reported voice outcomes: The VAS voice.

Authors:  Matthew R Naunheim; Jennifer B Dai; Benjamin J Rubinstein; Leanne Goldberg; Alan Weinberg; Mark S Courey
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.